{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:58Z","timestamp":1792788898448,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-026-07965-8","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:19:18Z","timestamp":1769872758000},"page":"1765-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frailty phenotypes and determinants of glucocorticoid-related adverse events in polymyalgia rheumatica at 12\u00a0months: a real-life single-center investigation"],"prefix":"10.1007","volume":"45","author":[{"given":"Elvis","family":"Hysa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Iandolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Balito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Mairone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Gotelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Campitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pizzorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-0932","authenticated-orcid":false,"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"10411","key":"7965_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/s0140-6736(23)01310-7","volume":"402","author":"G Esp\u00edgol-Frigol\u00e9","year":"2023","unstructured":"Esp\u00edgol-Frigol\u00e9 G, Dejaco C, Mackie SL, Salvarani C, Matteson EL, Cid MC (2023) Polymyalgia rheumatica. Lancet 402(10411):1459\u20131472. https:\/\/doi.org\/10.1016\/s0140-6736(23)01310-7","journal-title":"Lancet"},{"issue":"5 Suppl 68","key":"7965_CR2","first-page":"S143","volume":"29","author":"R Caporali","year":"2011","unstructured":"Caporali R, Cimmino MA, Montecucco C, Cutolo M (2011) Glucocorticoid treatment of polymyalgia rheumatica. Clin Exp Rheumatol 29(5 Suppl 68):S143-7","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"7965_CR3","first-page":"1219","volume":"33","author":"RH Straub","year":"2006","unstructured":"Straub RH, Cutolo M (2006) Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica. J Rheumatol 33(7):1219\u20131223","journal-title":"J Rheumatol"},{"key":"7965_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb03142.x","volume":"992","author":"M Cutolo","year":"2003","unstructured":"Cutolo M, Sulli A, Pizzorni C, Craviotto C, Straub RH (2003) Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann N Y Acad Sci 992:107\u201317. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb03142.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"7965_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","volume":"41","author":"A Floris","year":"2022","unstructured":"Floris A, Piga M, Chessa E, Congia M, Erre GL, Angioni MM, Mathieu A et al (2022) Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol 41(1):19\u201331. https:\/\/doi.org\/10.1007\/s10067-021-05819-z","journal-title":"Clin Rheumatol"},{"issue":"5","key":"7965_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5114\/reum.2021.110600","volume":"59","author":"E Hysa","year":"2021","unstructured":"Hysa E, Ghorbannia A, Emamifar A, Milchert M, Manzo C (2021) Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature. Reumatologia 59(5):323\u2013329. https:\/\/doi.org\/10.5114\/reum.2021.110600","journal-title":"Reumatologia"},{"issue":"2","key":"7965_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/rheumatology\/kead471","volume":"63","author":"E Hysa","year":"2024","unstructured":"Hysa E, Bond M, Ehlers L, Camellino D, Falzon L, Dejaco C, Buttgereit F et al (2024) Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review. Rheumatology (Oxford) 63(2):285\u201397. https:\/\/doi.org\/10.1093\/rheumatology\/kead471","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7965_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/reum\/170845","volume":"61","author":"E Hysa","year":"2023","unstructured":"Hysa E, Vojinovic T, Gotelli E, Alessandri E, Pizzorni C, Paolino S, Sulli A et al (2023) The dichotomy of glucocorticosteroid treatment in immune-inflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice. Reumatologia 61(4):283\u201393. https:\/\/doi.org\/10.5114\/reum\/170845","journal-title":"Reumatologia"},{"issue":"12","key":"7965_CR9","doi-asserted-by":"publisher","first-page":"e881","DOI":"10.1016\/s2665-9913(24)00191-7","volume":"6","author":"SB Lieber","year":"2024","unstructured":"Lieber SB, Wysham KD, Sattui SE, Yung R, Misra D (2024) Frailty and rheumatic diseases: evidence to date and lessons learned. Lancet Rheumatol 6(12):e881\u2013e891. https:\/\/doi.org\/10.1016\/s2665-9913(24)00191-7","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"7965_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105864","volume":"92","author":"A Tournadre","year":"2025","unstructured":"Tournadre A (2025) Frailty during polymyalgia rheumatica, giant cell arteritis and other inflammatory rheumatic diseases. Joint Bone Spine 92(4):105864. https:\/\/doi.org\/10.1016\/j.jbspin.2025.105864","journal-title":"Joint Bone Spine"},{"issue":"4","key":"7965_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/mr\/roaf001","volume":"35","author":"Y Tanaka","year":"2025","unstructured":"Tanaka Y, Takahashi T, Inokuchi S, Uenaka H, Fujita A, Sakamoto K (2025) Characteristics of patients with polymyalgia rheumatica based on glucocorticoid dose in Japan: a cohort study using routinely collected health data. Mod Rheumatol 35(4):722\u201330. https:\/\/doi.org\/10.1093\/mr\/roaf001","journal-title":"Mod Rheumatol"},{"key":"7965_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-005650","author":"Y Tanaka","year":"2025","unstructured":"Tanaka Y, Takahashi T, Fukasawa T, Inokuchi S, Uenaka H, Fujita A, Shimamoto K et al (2025) Trajectory analysis of glucocorticoid treatment highlights issues in the current tapering strategy for polymyalgia rheumatica. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2025-005650","journal-title":"RMD Open"},{"issue":"7","key":"7965_CR13","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s11739-023-03373-x","volume":"18","author":"E Conticini","year":"2023","unstructured":"Conticini E, Falsetti P, d\u2019Alessandro M, Al Khayyat SG, Grazzini S, Baldi C, Acciai C et al (2023) Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study\u202f: Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound. Intern Emerg Med 18(7):1929\u20131939. https:\/\/doi.org\/10.1007\/s11739-023-03373-x","journal-title":"Intern Emerg Med"},{"issue":"1","key":"7965_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105093","volume":"88","author":"N Giraud","year":"2021","unstructured":"Giraud N, Prati C, Wendling D, Verhoeven F (2021) Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumatica. Joint Bone Spine 88(1):105093. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105093","journal-title":"Joint Bone Spine"},{"issue":"3","key":"7965_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkab091","volume":"5","author":"A Emamifar","year":"2021","unstructured":"Emamifar A, Hess S, Ellingsen T, Gerke O, Ahangarani Farahani Z, Syrak Hansen P, Jensen Hansen IM et al (2021) Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up. Rheumatol Adv Pract 5(3):rkab091. https:\/\/doi.org\/10.1093\/rap\/rkab091","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"7965_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","volume":"62","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Mitnitski A (2007) Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 62(7):722\u2013727. https:\/\/doi.org\/10.1093\/gerona\/62.7.722","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7965_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.06.2126","author":"ML Soowamber","year":"2025","unstructured":"Soowamber ML, Bond M, Touma Z, Langford C, Sanchez-Alvarez C, Abril A, Aydin SZ et al (2025) A glossary of signs and symptoms of giant cell arteritis. Ann Rheum Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.06.2126","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7965_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484\u201392. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7965_CR19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u201381. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"12","key":"7965_CR20","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/art.42325","volume":"74","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A et al (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Arthritis Rheumatol 74(12):1881\u20139. https:\/\/doi.org\/10.1002\/art.42325","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"7965_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/rheumatology\/ken294","volume":"48","author":"M Cutolo","year":"2009","unstructured":"Cutolo M, Cimmino MA, Sulli A (2009) Polymyalgia rheumatica vs late-onset rheumatoid arthritis. Rheumatology (Oxford) 48(2):93\u201395. https:\/\/doi.org\/10.1093\/rheumatology\/ken294","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"7965_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/ard.2010.133850","volume":"70","author":"C Dejaco","year":"2011","unstructured":"Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, Maradit-Kremers H et al (2011) Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis 70(3):447\u201353. https:\/\/doi.org\/10.1136\/ard.2010.133850","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7965_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.autrev.2007.11.019","volume":"7","author":"M Cutolo","year":"2008","unstructured":"Cutolo M, Straub RH (2008) Circadian rhythms in arthritis: hormonal effects on the immune\/inflammatory reaction. Autoimmun Rev 7(3):223\u20138. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.019","journal-title":"Autoimmun Rev"},{"issue":"8","key":"7965_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.autrev.2005.04.019","volume":"4","author":"M Cutolo","year":"2005","unstructured":"Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease\u2019s symptoms. Autoimmun Rev 4(8):497\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2005.04.019","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7965_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000426","volume":"3","author":"M Cutolo","year":"2017","unstructured":"Cutolo M, Hopp M, Liebscher S, Dasgupta B, Buttgereit F (2017) Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study. RMD Open 3(1):e000426. https:\/\/doi.org\/10.1136\/rmdopen-2016-000426","journal-title":"RMD Open"},{"issue":"3","key":"7965_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/wics.1597","volume":"15","author":"A Jaeger","year":"2023","unstructured":"Jaeger A, Banks D (2023) Cluster analysis: a modern statistical review. WIREs Comput Stat 15(3):e1597. https:\/\/doi.org\/10.1002\/wics.1597","journal-title":"WIREs Comput Stat"},{"issue":"11","key":"7965_CR27","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1093\/rheumatology\/keac050","volume":"61","author":"SE Sattui","year":"2022","unstructured":"Sattui SE, Jannat-Khah D, Lally L, Lieber SB, Mandl LA, Spiera RF (2022) Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia. Rheumatology (Oxford) 61(11):4455\u20134464. https:\/\/doi.org\/10.1093\/rheumatology\/keac050","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7965_CR28","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/rheumatology\/kez533","volume":"59","author":"S Muller","year":"2020","unstructured":"Muller S, Whittle R, Hider SL, Belcher J, Helliwell T, Morton C, Hughes E et al (2020) Longitudinal clusters of pain and stiffness in polymyalgia rheumatica: 2-year results from the PMR Cohort Study. Rheumatology (Oxford) 59(8):1906\u201315. https:\/\/doi.org\/10.1093\/rheumatology\/kez533","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7965_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1757-y","volume":"20","author":"R Partington","year":"2018","unstructured":"Partington R, Helliwell T, Muller S, Abdul Sultan A, Mallen C (2018) Comorbidities in polymyalgia rheumatica: a systematic review. Arthritis Res Ther 20(1):258. https:\/\/doi.org\/10.1186\/s13075-018-1757-y","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"7965_CR30","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1136\/annrheumdis-2018-213883","volume":"77","author":"RJ Partington","year":"2018","unstructured":"Partington RJ, Muller S, Helliwell T, Mallen CD, Abdul Sultan A (2018) Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study. Ann Rheum Dis 77(12):1750\u20131756. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213883","journal-title":"Ann Rheum Dis"},{"key":"7965_CR31","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/z9264f","author":"MA Cimmino","year":"2025","unstructured":"Cimmino MA, Camellino D, Clini PV, Cutolo M, Hysa E (2025) Polypharmacy and comorbidities are not higher at diagnosis in patients with polymyalgia rheumatica compared to osteoarthritis. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/z9264f","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"7965_CR32","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1093\/rheumatology\/keae531","volume":"64","author":"S Cowley","year":"2025","unstructured":"Cowley S, Harkins P, Kirby C, Conway R, Kane D (2025) Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic. Rheumatology (Oxford) 64(5):3006\u20133011. https:\/\/doi.org\/10.1093\/rheumatology\/keae531","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"7965_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med 17(12):e1003432. https:\/\/doi.org\/10.1371\/journal.pmed.1003432","journal-title":"PLoS Med"},{"issue":"5","key":"7965_CR34","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40744-024-00707-9","volume":"11","author":"N Ohkubo","year":"2024","unstructured":"Ohkubo N, Miyazaki Y, Nakayamada S, Fukuyo S, Inoue Y, Satoh-Kanda Y, Tanaka H et al (2024) Efficacy and safety of biologics in polymyalgia rheumatica: a retrospective study. Rheumatol Ther 11(5):1303\u201319. https:\/\/doi.org\/10.1007\/s40744-024-00707-9","journal-title":"Rheumatol Ther"},{"issue":"10","key":"7965_CR35","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A et al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74(10):1799\u2013807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07965-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:53:38Z","timestamp":1771581218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7965"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07965-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors give final approval of the version that will be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}